Palapas, Jasper Riva A.

HRN: 10-61-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2026
CO-AMOXICLAV 625MG (TAB)
05/19/2026
05/26/2026
PO
625mg
BID X 7 Days
S/P NSVD With RMLE; UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: